Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple myeloma
Pharma
Elrexfio ph. 3 win tees up label expansion in multiple myeloma
Pfizer's Elrexfio decreased risk of disease progression and death in RRMM patients whose disease worsened after frontline options.
Donavyn Coffey
Oct 27, 2026 11:15am
BMS is augmenting Zenbexus' efficacy profile in multiple myeloma
Oct 8, 2026 2:25pm
BMS bags first FDA approval for CELMoD franchise with Zenbexus
Aug 14, 2026 10:09am
With cash dwindling and a loan due, Karyopharm faces default
Aug 13, 2026 2:52pm
Legend interim CEO talks transition, Carvykti challenges
Aug 12, 2026 2:44pm
J&J bispecific combo delivers 89% PFS benefit in myeloma
Jul 23, 2026 8:30am
